Literature DB >> 16920077

Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.

G Paul Amminger1, Gregor E Berger, Miriam R Schäfer, Claudia Klier, Max H Friedrich, Martha Feucht.   

Abstract

BACKGROUND: There is increasing evidence that fatty acid deficiencies or imbalances may contribute to childhood neurodevelopmental disorders.
METHODS: We conducted a randomized, double-blind, placebo-controlled 6-week pilot trial investigating the effects of 1.5 g/d of omega-3 fatty acids (.84 g/d eicosapentaenoic acid, .7 g/d docosahexaenoic acid) supplementation in 13 children (aged 5 to 17 years) with autistic disorders accompanied by severe tantrums, aggression, or self-injurious behavior. The outcome measure was the Aberrant Behavior Checklist (ABC) at 6 weeks.
RESULTS: We observed an advantage of omega-3 fatty acids compared with placebo for hyperactivity and stereotypy, each with a large effect size. Repeated-measures ANOVA indicated a trend toward superiority of omega-3 fatty acids over placebo for hyperactivity. No clinically relevant adverse effects were elicited in either group.
CONCLUSIONS: The results of this study provide preliminary evidence that omega-3 fatty acids may be an effective treatment for children with autism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920077     DOI: 10.1016/j.biopsych.2006.05.007

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  70 in total

Review 1.  Management of schizophrenia in children and adolescents: focus on pharmacotherapy.

Authors:  Gabriele Masi; Francesca Liboni
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

Review 2.  Improving the prediction of response to therapy in autism.

Authors:  Stephen Bent; Robert L Hendren
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 3.  Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families.

Authors:  R Scott Akins; Kathy Angkustsiri; Robin L Hansen
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 4.  Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications.

Authors:  Evdokia Anagnostou; Robin Hansen
Journal:  Curr Opin Pediatr       Date:  2011-12       Impact factor: 2.856

5.  Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids.

Authors:  Francis E Lotrich; Barry Sears; Robert K McNamara
Journal:  J Psychosom Res       Date:  2013-07-26       Impact factor: 3.006

6.  Treatment of Autism Spectrum Disorder in Children and Adolescents.

Authors:  Melissa DeFilippis; Karen Dineen Wagner
Journal:  Psychopharmacol Bull       Date:  2016-08-15

7.  Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism.

Authors:  Stephen Bent; Robert L Hendren; Tara Zandi; Kiely Law; Jae-Eun Choi; Felicia Widjaja; Luther Kalb; Jay Nestle; Paul Law
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-03-12       Impact factor: 8.829

8.  The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis.

Authors:  Cheryl M Corcoran; Michael B First; Barbara Cornblatt
Journal:  Schizophr Res       Date:  2010-04-08       Impact factor: 4.939

Review 9.  Omega-3 fatty acids for autistic spectrum disorder: a systematic review.

Authors:  Stephen Bent; Kiah Bertoglio; Robert L Hendren
Journal:  J Autism Dev Disord       Date:  2009-03-31

10.  Complementary alternative medicine for children with autism: a physician survey.

Authors:  Allison E Golnik; Marjorie Ireland
Journal:  J Autism Dev Disord       Date:  2009-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.